icon-folder.gif   Conference Reports for NATAP  
61th Annual Meeting of the American Association for the Study of Liver Diseases
Boston, MA, Hynes Convention Center
October 30-November 3, 2010
Back grey_arrow_rt.gif
IMO-2125, a TLR9 Agonist, Induces Immune ResponsesWhich Correlate With Reductions In Viral Load In Null Responder HCV Patients
  Reported by Jules Levin
AASLD Nov 1 2010 Boston
M Rodriguez-Torres, RH Ghalib, SC Gordon, E Lawitz,K Patel, R Pruitt, AM Sheikh, RD Arbeit, AS Bexon, ER Kandimalla, M Precopio, T Sullivan, AJ Muir, JG McHutchison